Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Frequency/quantity</td><td align="center">Score</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Abstinence</td><td align="center">0.00</td></tr><tr><td align="left">Once a week or less</td><td align="center">0.01–0.13</td></tr><tr><td align="left">More than once a week</td><td align="center">0.14–0.99</td></tr><tr><td align="left">Daily</td><td align="center">1.00–1.99</td></tr><tr><td align="left">More than once a day</td><td align="center">2.00 or more</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Opiate treatment index scores interpretation table.

Advances in Preventive Medicine

tab5

Table 5

Table 5: Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup 